Marjan Farid1, Roger F Steinert. 1. Gavin Herbert Eye Institute, University of California, Irvine, California 92697-4375, USA. mfarid@uci.edu
Abstract
PURPOSE OF REVIEW: To investigate the preoperative characteristics and updated patient selection criteria for presbyopic patients undergoing laser refractive surgery for monovision. RECENT FINDINGS: The role of age, sex, ocular dominance, amount of monovision, and hyperopic versus myopic treatments is reviewed and reported. The presbyopic female patient is less likely to reject monovision. Patients with a strong sighting preference do less well due to reduced interocular blur suppression. Although myopes represent the majority of monovision patients, laser-corrected monovision in hyperopes is a viable and satisfactory option. SUMMARY: Refractive surgery monovision correction represents an increasingly popular method for the presbyopic patient. Patient selection based on multiple preoperative characteristics is vitally important to the overall success and patient satisfaction.
PURPOSE OF REVIEW: To investigate the preoperative characteristics and updated patient selection criteria for presbyopic patients undergoing laser refractive surgery for monovision. RECENT FINDINGS: The role of age, sex, ocular dominance, amount of monovision, and hyperopic versus myopic treatments is reviewed and reported. The presbyopic female patient is less likely to reject monovision. Patients with a strong sighting preference do less well due to reduced interocular blur suppression. Although myopes represent the majority of monovision patients, laser-corrected monovision in hyperopes is a viable and satisfactory option. SUMMARY: Refractive surgery monovision correction represents an increasingly popular method for the presbyopic patient. Patient selection based on multiple preoperative characteristics is vitally important to the overall success and patient satisfaction.
Authors: James A Katz; Paul M Karpecki; Alexandra Dorca; Sima Chiva-Razavi; Heather Floyd; Elizabeth Barnes; Mark Wuttke; Eric Donnenfeld Journal: Clin Ophthalmol Date: 2021-05-24